ASC 718 vs IFRS 2 — Core Rule
ASC 718 (Share-Based Payment Arrangements) and IFRS 2 (Share-Based Payment) both require entities to recognize an expense for equity-settled and cash-settled share awards, but they diverge fundamentally on when to measure fair value (measurement date rules), how to account for post-vesting modifications, and whether forfeiture must be estimated upfront or reversed as actual forfeitures occur.
How ASC 718 vs IFRS 2 Works
- Measurement date — the biggest difference. Under ASC 718-10-30-6, equity-settled awards are measured at grant date fair value and never remeasured. IFRS 2:19-22 requires measurement at grant date for equity-settled awards but continues to remeasure until the entity has no further obligation—creating fair value volatility for cash-settled awards. For cash-settled share appreciation rights (SARs), ASC 718-10-30-2 remeasures at each reporting date through settlement; IFRS 2:30 does the same, but the mechanics and timing of expense reversal differ significantly.
- Vesting condition treatment. ASC 718-10-30-1 allows entities to estimate the expected number of awards that will vest based on service and performance conditions; forfeitures are estimated at grant date and adjusted over the vesting period. IFRS 2:19 similarly requires probability estimates for vesting, but IFRS 2 provides stricter guidance on accounting for modifications. Under ASC 718-20-35-3, a modification that increases intrinsic value triggers additional expense equal to the incremental fair value; IFRS 2:26–28 requires comparison of the award's fair value before and after modification, recognizing the greater of the two.
- Forfeiture accounting — election vs. requirement. ASC 718-10-30-4 permits entities to elect either (1) estimating forfeitures at grant date or (2) recognizing forfeitures as they occur, adjusting cumulative expense. This election is by class of award. IFRS 2 does not provide an explicit election; rather, it builds into the grant-date estimate an assessment of the probability that conditions will be satisfied, and entities adjust if circumstances change (IFRS 2:19). Many US GAAP preparers incorrectly assume they must estimate; under ASC 718-10-30-4(b), the actual forfeiture method (reverse expense when employees leave) is equally compliant.
- Cash-settled awards and liability remeasurement. Both standards require cash-settled awards (and liability-classified awards) to be remeasured at fair value each period. However, ASC 718-10-30-2 remeasures through the settlement date; IFRS 2:30 remeasures through the vesting date for cash-settled awards, with any post-vesting changes flowing through profit/loss. This creates a timing difference in expense recognition for multi-year cash awards when the settlement date extends beyond vesting.
- Presentation and disclosure scope. ASC 718-10-50-1 requires detailed disclosure of the nature and terms of arrangements, weighted-average fair values, and inputs to valuation models. IFRS 2:44–52 mandates similar disclosures but additionally requires entities to disclose the weighted-average remaining contractual life (IFRS 2:45) and reconciliations of the number of instruments outstanding. For multinational filers (20-F registrants), IFRS 2 compliance is typically stricter on this front.
ASC 718 vs IFRS 2 — Practical Example
Scenario: Acme Corp. grants 10,000 RSUs to a VP on 1/1/2024 at a fair value of $50/unit. The award vests 50% on 1/1/2025 and 50% on 1/1/2026. The employee leaves on 6/30/2025 (no vesting acceleration). Stock price: $50 on grant date, $60 on 12/31/2024, $55 on 6/30/2025.
Under ASC 718 (Estimated Forfeiture Method)
Grant-date fair value: 10,000 × $50 = $500,000
Assume 5% forfeiture probability at grant date: $500,000 × 95% = $475,000
2024 expense (1/2 of vesting): $475,000 / 2 = $237,500
Journal Entry 12/31/2024:
DR Compensation Expense $237,500
CR Additional Paid-in Capital $237,500
On 6/30/2025, employee leaves before second vesting tranche (5,000 RSUs forfeit):
Reversal of unrecognized expense (2025 half): $237,500
Journal Entry 6/30/2025:
DR Additional Paid-in Capital $237,500
CR Compensation Expense $237,500
Settlement of 5,000 RSUs at $55: $275,000 cash paid.
Under IFRS 2 (Probability-Based Estimate)
Probability-adjusted grant-date fair value: 10,000 × $50 × 95% = $475,000
Same vesting-schedule expense: $237,500 per year through vesting date.
When employee departs, the adjustment is immediate (no reversal of 2025 expense; instead, the probability estimate is reset to reflect actual outcome). Treatment is less mechanically reversible and more judgment-driven.
ASC 718 vs IFRS 2 — Common Pitfalls
- Confusing measurement date with re-measurement. Many practitioners misread ASC 718-10-30-6 as requiring no revaluation for equity awards ever; in fact, cash-settled SARs and liability-classified awards must be remeasured. The "no remeasurement" rule applies only to equity-settled awards where grant-date fair value is locked in forever.
- Applying IFRS forfeiture logic under US GAAP. Teams migrating from IFRS to US GAAP often assume they must estimate forfeitures; ASC 718-10-30-4(b) explicitly permits the actual forfeiture method, which simplifies auditing and reduces estimate risk. Election by award class allows flexibility.
- Modification accounting mismatch. ASC 718-20-35-3 (incremental fair value method) is often confused with IFRS 2:26 (greater-of method). Incorrectly applying IFRS logic can overstate expense. For stock options with repricing, ASC 718-20-35-8 applies a specific anti-abuse rule that IFRS 2 does not.
ASC 718 vs IFRS 2 — Key Paragraphs
- ASC 718-10-30-1, 30-2, 30-4, 30-6 (measurement and forfeiture)
- ASC 718-20-35-3 (modification accounting—incremental fair value)
- IFRS 2:19–28 (measurement and modifications)
- IFRS 2:30 (cash-settled awards)
- IFRS 2:44–52 (disclosure requirements)